Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Transplant ; 11(3): 528-35, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-21219580

RESUMO

Early risk-prediction is essential to prevent cardiac allograft vasculopathy (CAV) and graft failure in heart transplant patients. We developed multivariate models to identify patients likely to experience CAV, severe CAV, and failure due to CAV, at 1, 5 and 10 years. A cohort of 172 patients was followed prospectively for 6.7 ± 3.9 years. Logistic regression models were developed and cross-validated using bootstrap resampling. Predictive markers of atherothrombosis (myocardial fibrin deposition, and loss of vascular antithrombin and tissue plasminogen activator) and arterial endothelial activation (intercellular adhesion molecule-1 expression) were measured in serial biopsies obtained within 3 months posttransplant. Most markers were univariately associated with outcome. Multivariate models showed that loss of tissue plasminogen activator was the dominant and, in most cases, only predictor of long-term CAV (p < 0.001), severe CAV (p < 0.001), and graft failure due to CAV (p < 0.001). The models discriminated patients having adverse outcomes, had particularly high negative predictive values (graft failure due to CAV: 99%, 99% and 95% at 1, 5 and 10 years) and predicted event incidence and time to event. Early absence of atherothrombotic risk identifies a patient subgroup that rarely develops CAV or graft failure, implying that this low-risk subgroup could possibly be followed with fewer invasive procedures.


Assuntos
Biomarcadores/metabolismo , Rejeição de Enxerto/diagnóstico , Insuficiência Cardíaca/diagnóstico , Transplante de Coração/efeitos adversos , Doenças Vasculares/diagnóstico , Doenças Vasculares/etiologia , Adulto , Diagnóstico Precoce , Feminino , Rejeição de Enxerto/etiologia , Rejeição de Enxerto/metabolismo , Insuficiência Cardíaca/etiologia , Insuficiência Cardíaca/metabolismo , Humanos , Técnicas Imunoenzimáticas , Masculino , Pessoa de Meia-Idade , Modelos Estatísticos , Prognóstico , Estudos Prospectivos , Fatores de Risco , Transplante Homólogo , Doenças Vasculares/metabolismo
2.
Chem Biol Interact ; 19(3): 259-64, 1977 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-597961

RESUMO

The effect of ferric and manganese ions on the in vitro metabolism of benzo(a)pyrene (BP) to dihydrodihydroxy (diol) metabolites by rat liver microsomal preparations was studied. Of the 3 diols separated by high-pressure liquid chromatography (HPLC) and called diols 1, 2 and 3 in order of elution, diol 1 was identified by its U.V. spectrum as the 9,10-diol; diols 2 and 3 have not yet been identified positively but are probably the 4,5- and 7,8-diols respectively. Higher concentrations of both metals altered the diol profile; 10 and 50 mumol Fe3+ per incubation caused the disappearance of diols 1 and 2 and an increase in diol 3; 10 mumol Mn2+ caused a significant decrease in diol 2 while 50 mumol reduced diol 2 to a negligible amount and inhibited the formation of diol 1; both concentrations caused a relative increase in diol 3. If the tentative identification of diol 3 as the 7,8-diol is correct, manganese and ferric ions could be significant in the metabolism of BP to the active metabolite, the 7,8-diol-9,10-epoxide.


Assuntos
Benzopirenos/metabolismo , Compostos Férricos/farmacologia , Ferro/farmacologia , Manganês/farmacologia , Microssomos Hepáticos/metabolismo , Animais , Benzopirenos/análise , Cromatografia Líquida de Alta Pressão , Cromatografia em Camada Fina , Técnicas In Vitro , Ratos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...